Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1977 1
2014 2
2015 1
2017 1
2018 4
2019 5
2020 5
2021 1
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Azithromycin.
Bakheit AH, Al-Hadiya BM, Abd-Elgalil AA. Bakheit AH, et al. Profiles Drug Subst Excip Relat Methodol. 2014;39:1-40. doi: 10.1016/B978-0-12-800173-8.00001-5. Profiles Drug Subst Excip Relat Methodol. 2014. PMID: 24794904 Review.
Sorafenib.
Abdelgalil AA, Alkahtani HM, Al-Jenoobi FI. Abdelgalil AA, et al. Profiles Drug Subst Excip Relat Methodol. 2019;44:239-266. doi: 10.1016/bs.podrm.2018.11.003. Epub 2019 Jan 18. Profiles Drug Subst Excip Relat Methodol. 2019. PMID: 31029219
Telmisartan.
Bakheit AH, Abd-Elgalil AA, Mustafa B, Haque A, Wani TA. Bakheit AH, et al. Profiles Drug Subst Excip Relat Methodol. 2015;40:371-429. doi: 10.1016/bs.podrm.2015.01.003. Epub 2015 Mar 31. Profiles Drug Subst Excip Relat Methodol. 2015. PMID: 26051689 Review.
Erlotinib.
Abdelgalil AA, Al-Kahtani HM, Al-Jenoobi FI. Abdelgalil AA, et al. Profiles Drug Subst Excip Relat Methodol. 2020;45:93-117. doi: 10.1016/bs.podrm.2019.10.004. Epub 2019 Dec 6. Profiles Drug Subst Excip Relat Methodol. 2020. PMID: 32164971
Imatinib mesylate.
Al-Hadiya BM, Bakheit AH, Abd-Elgalil AA. Al-Hadiya BM, et al. Profiles Drug Subst Excip Relat Methodol. 2014;39:265-97. doi: 10.1016/B978-0-12-800173-8.00006-4. Profiles Drug Subst Excip Relat Methodol. 2014. PMID: 24794909 Review.
Crizotinib: A comprehensive profile.
Abdelgalil AA, Alkahtani HM. Abdelgalil AA, et al. Profiles Drug Subst Excip Relat Methodol. 2023;48:39-69. doi: 10.1016/bs.podrm.2022.11.002. Epub 2023 Feb 2. Profiles Drug Subst Excip Relat Methodol. 2023. PMID: 37061275
Lapatinib: A comprehensive profile.
Abdelgalil AA, Alkahtani HM. Abdelgalil AA, et al. Profiles Drug Subst Excip Relat Methodol. 2023;48:135-166. doi: 10.1016/bs.podrm.2022.11.005. Epub 2022 Dec 26. Profiles Drug Subst Excip Relat Methodol. 2023. PMID: 37061273
Regorafenib: A comprehensive drug profile.
Abdelgalil AA, Alkahtani HM. Abdelgalil AA, et al. Profiles Drug Subst Excip Relat Methodol. 2024;49:41-79. doi: 10.1016/bs.podrm.2023.11.004. Epub 2023 Dec 7. Profiles Drug Subst Excip Relat Methodol. 2024. PMID: 38423709
29 results